Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

Slides:

Advertisements

Similar presentations

4S: Scandinavian Simvastatin Survival Study

Advertisements

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

My Treatment Approach to Gout

From Inuit to Implementation: Omega-3 Fatty Acids Come of Age

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational.

A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids.

Contemporary Diagnosis and Management of Unstable Angina

Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids.

Congestive Heart Failure in Elderly Patients

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Joerg Herrmann, MD, Amir Lerman, MD, Nicole P

William L. Lanier, MD Mayo Clinic Proceedings

A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs Charles E. Argoff,

Cardiac Cell Repair Therapy: A Clinical Perspective

My Treatment Approach to Gout

Can Vitamin D Deficiency Break Your Heart?

Step Care Therapy for Hypertension in Diabetic Patients

Sudden Cardiac Death From the Perspective of Coronary Artery Disease

Peripheral Arterial Disease: Diagnosis and Management

Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story

George Dailey, MD Mayo Clinic Proceedings

Palliative Care and Hospice Programs

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

George E. Kikano, MD, Marie T. Brown, MD Mayo Clinic Proceedings

Sexual Activity and Chronic Heart Failure

Quantitating the Dose of Physical Activity in Secondary Prevention: Relation of Exercise Intensity to Survival Barry A. Franklin, PhD Mayo Clinic Proceedings

Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit Barry A. Franklin, PhD Mayo.

Efficacy and Safety of Thrombin-Receptor Antagonist (Atopaxar and Vorapaxar) in Patients with Acute Coronary Syndrome or Coronary Artery Disease—A Meta-Analysis.

Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials Sripal Bangalore, MD, MHA, Harikrishna Makani, MD,

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery Maral Ouzounian, MD, Karen J. Buth, MS,

Acute Kidney Injury and Death Associated With Renin Angiotensin System Blockade in Cardiothoracic Surgery: A Meta-analysis of Observational Studies Rabi.

Successes and failures of current treatment of heart failure

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Medical management of osteoarthritis

R. Scott Wright, MD, Stephen L. Kopecky, MD, Guy S. Reeder, MD

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Peripartum Cardiomyopathy Presenting as an Acute Myocardial Infarction

Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care Marc Cohen, MD Mayo Clinic Proceedings

Flow Diagram of the Trial Selection Process

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Age-dependent care and long-term (20year) mortality of 14,434 myocardial infarction patients: Changes from 1985 to 2008 Sjoerd T. Nauta, Jaap W. Deckers,

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S

From Inuit to Implementation: Omega-3 Fatty Acids Come of Age

Eduardo Marbán, MD, PhD Mayo Clinic Proceedings

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus James H. O'Keefe, MD, Mohammad Abuannadi,

Effects of Niacin on Glucose Control in Patients With Dyslipidemia

Serial Measurement of Serum Tryptase in Angiotensin-Converting Enzyme Inhibitor- Associated Angioedema Kevin R. Regner, MD, Douglas L. Riegert-Johnson,

Medical Treatment of Overactive Bladder: In Response

Marrick L. Kukin, MD Mayo Clinic Proceedings

Coronary Revascularization on Balance: Robert L. Frye Lecture

Carmine Zoccali, Francesca Mallamaci Kidney International

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Guy S. Reeder, M.D. Mayo Clinic Proceedings

Autonomic Tone and Benefits of Cardiac Rehabilitation Programs

Guy S. Reeder, M.D., Raymond J. Gibbons, M.D. Mayo Clinic Proceedings

Surviving Heart Failure: Robert L. Frye Lecture

β-Blocker Use for the Stages of Heart Failure

Acute and Chronic Seizures in Patients Older Than 60 Years

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Presentation transcript:

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes Wayne L. Miller, MD, PHD, Guy S. Reeder, MD Mayo Clinic Proceedings Volume 76, Issue 4, Pages 391-405 (April 2001) DOI: 10.4065/76.4.391 Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 1 Trend in β-blocker therapy use after myocardial infarction based on data from the Worcester Heart Attack Study (adapted with permission from McCormick et al42). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 2 β-Blocker therapy in the elderly based on data from the New Jersey Community Post-MI Study, 1987–1992. MI = myocardial infarction (adapted with permission from Soumerai et al43). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 3 Effect of nitrate therapy on short-term mortality after acute myocardial infarction. CEI = converting enzyme inhibitors; CI = confidence interval; IV = intravenous; N = nitrate (adapted with permission from ISIS-4 Collaborative Group45). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 4 Angiotensin-converting enzyme inhibitor (ACE-I) therapy in 30-day mortality after myocardial infarction. CI = confidence interval; O - E = observed minus expected (adapted with permission from the ISIS-4 Collaborative Group45). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 5 Effect of angiotensin-converting enzyme inhibitor therapy on sudden cardiac death based on a meta-analysis that included 15,104 patients (adapted with permission from Domanski et al52). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 6 Amiodarone therapy after acute myocardial infarction based on meta-analysis of 6500 patients. CI = confidence interval (adapted with permission from Amiodarone Trials Meta-Analysis Investigators65). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 7 4S survival trial data in patients with angina after myocardial infarction (left ventricular dysfunction excluded) (adapted with permission from Scandinavian Simvastatin Survival Study Group68). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 8 Effect of intravenous magnesium therapy on short-term mortality after acute myocardial infarction based on randomized trial data. CI = confidence interval; NS = not significant (adapted with permission from ISIS-4 Collaborative Group45). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 9 Effect of estrogen/progestin on nonfatal myocardial infarction. CAD = coronary artery disease (adapted with permission from Hulley et al81). Mayo Clinic Proceedings 2001 76, 391-405DOI: (10.4065/76.4.391) Copyright © 2001 Mayo Foundation for Medical Education and Research Terms and Conditions